Literature DB >> 28881915

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

A Hochhaus1, S Saussele2, G Rosti3, F-X Mahon4, J J W M Janssen5, H Hjorth-Hansen6, J Richter7, C Buske8.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28881915     DOI： 10.1093/annonc/mdx219

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  90 in total

1.  First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis.

Authors:  Claudia Vener; Rita Banzi; Federico Ambrogi; Annalisa Ferrero; Giuseppe Saglio; Gabriella Pravettoni; Milena Sant
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  Molecular monitoring in CML: how deep? How often? How should it influence therapy?

Authors:  Naranie Shanmuganathan; Timothy P Hughes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.

Authors:  Rintaro Sogawa; Sakiko Kimura; Ryota Yakabe; Yasuhito Mizokami; Masanobu Tasaki; Naoko Sueoka-Aragane; Yutaka Narisawa; Shinya Kimura
Journal:  Int J Clin Oncol       Date:  2018-04-12       Impact factor: 3.402

4.  Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey.

Authors:  Pinkie Chambers; Kenneth K C Man; Vivian W Y Lui; Sheila Mpima; Paola Nasuti; Martin D Forster; Ian C K Wong
Journal:  JCO Oncol Pract       Date:  2020-03-11

Review 5.  Early Management of CML.

Authors:  Naranie Shanmuganathan; Timothy P Hughes
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

6.  Effect of study-level factors on treatment-free remission rate in patients with chronic myeloid leukemia: a systematic review and meta-analysis.

Authors:  Jinchul Kim; Jisun Park; Yeonsook Moon; Suk Jin Choi; Joo Han Lim; Moon Hee Lee; Jinhyun Cho
Journal:  Int J Hematol       Date:  2019-09-27       Impact factor: 2.490

Review 7.  Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia.

Authors:  Massimo Breccia; Robin Foà
Journal:  Curr Oncol Rep       Date:  2018-03-06       Impact factor: 5.075

Review 8.  Dasatinib: A Review in Pediatric Chronic Myeloid Leukemia.

Authors:  Emma H McCafferty; Sohita Dhillon; Emma D Deeks
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

9.  B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.

Authors:  Gang Xiao; Lai N Chan; Lars Klemm; Daniel Braas; Zhengshan Chen; Huimin Geng; Qiuyi Chen Zhang; Ali Aghajanirefah; Kadriye Nehir Cosgun; Teresa Sadras; Jaewoong Lee; Tamara Mirzapoiazova; Ravi Salgia; Thomas Ernst; Andreas Hochhaus; Hassan Jumaa; Xiaoyan Jiang; David M Weinstock; Thomas G Graeber; Markus Müschen
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

10.  Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia.

Authors:  Shady Adnan Awad; Matti Kankainen; Teija Ojala; Perttu Koskenvesa; Samuli Eldfors; Bishwa Ghimire; Ashwini Kumar; Soili Kytölä; Mahmoud M Kamel; Caroline A Heckman; Kimmo Porkka; Satu Mustjoki
Journal:  Blood Adv       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.